Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (18150)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 7, 2016 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Haruyama Y, Kataoka H. Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma. World J Gastroenterol 2016; 22(1): 275-283 [PMID: 26755876 DOI: 10.3748/wjg.v22.i1.275] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i1/275.htm |
| Number | Citing Articles |
| 1 |
Takahiro Nishida, Hiroaki Kataoka. Glypican 3-Targeted Therapy in Hepatocellular Carcinoma. Cancers 2019; 11(9): 1339 doi: 10.3390/cancers11091339
|
| 2 |
Ying-Zhe Luo, Hong Zhu. Immunotherapy for advanced or recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2023; 15(3): 405-424 doi: 10.4251/wjgo.v15.i3.405
|
| 3 |
Peijun Liu, Weiqiu Li, Ganbin Qiu, Jincan Chen, Yonghui Liu, Zhongyan Wen, Mei Liang, Yue Zhao. Multiparametric MRI combined with clinical factors to predict glypican-3 expression of hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1142916
|
| 4 |
Pandjassarame Kangueane, Kumar Viswapoorani, Christina Nilofer, Subramani Manimegalai, Murugan Sivagamy, Uma Kangueane, Gopichandran Sowmya, Meena Kishore Sakharkar. Global Virology II - HIV and NeuroAIDS. 2017; : 925 doi: 10.1007/978-1-4939-7290-6_35
|
| 5 |
Bryan D. Fleming, Mitchell Ho. Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update. Biomolecules 2020; 10(6): 934 doi: 10.3390/biom10060934
|
| 6 |
Amisha Singh, Ryan J. Beechinor, Jasmine C. Huynh, Daneng Li, Farshid Dayyani, Jennifer B. Valerin, Andrew Hendifar, Jun Gong, May Cho. Immunotherapy Updates in Advanced Hepatocellular Carcinoma. Cancers 2021; 13(9): 2164 doi: 10.3390/cancers13092164
|
| 7 |
Yidi Chen, Yun Qin, Yuanan Wu, Hong Wei, Yi Wei, Zhen Zhang, Ting Duan, Hanyu Jiang, Bin Song. Preoperative prediction of glypican-3 positive expression in solitary hepatocellular carcinoma on gadoxetate-disodium enhanced magnetic resonance imaging. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.973153
|
| 8 |
Montalbano Mauro, Perricone Ugo, Zachary Walton, Shirafkan Ali, Cristiana Rastellini, Luca Cicalese. Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients. International Journal of Molecular Sciences 2023; 24(13): 10922 doi: 10.3390/ijms241310922
|
| 9 |
Lara Berklite, Archana Shenoy, Monica Hollowell, Bonita Fung, Sarangarajan Ranganathan. Focal Nodular Hyperplasia-Like Lesions With Glypican-3 Positivity in Infancy. Pediatric and Developmental Pathology 2023; 26(1): 30 doi: 10.1177/10935266221122934
|
| 10 |
Wei Cheng, Po-Chun Huang, Hsiao-Mei Chao, Yung-Ming Jeng, Hey-Chi Hsu, Hung-Wei Pan, Wuh-Liang Hwu, Yu-May Lee. Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10. Oncotarget 2017; 8(46): 80429 doi: 10.18632/oncotarget.19035
|
| 11 |
Camila Ordóñez-Reyes, Juan Esteban Garcia-Robledo, Diego F. Chamorro, Andrés Mosquera, Liliana Sussmann, Alejandro Ruiz-Patiño, Oscar Arrieta, Lucia Zatarain-Barrón, Leonardo Rojas, Alessandro Russo, Diego de Miguel-Perez, Christian Rolfo, Andrés F. Cardona. Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question. Pharmaceutics 2022; 14(6): 1243 doi: 10.3390/pharmaceutics14061243
|
| 12 |
Giulia Francesca Manfredi, Ciro Celsa, Chloe John, Charlotte Jones, Nicole Acuti, Bernhard Scheiner, Claudia Angela Maria Fulgenzi, James Korolewicz, Matthias Pinter, Alessandra Gennari, Francesco Mauri, Mario Pirisi, Rosalba Minisini, Federica Vincenzi, Michela Burlone, Cristina Rigamonti, Matteo Donadon, Giuseppe Cabibbo, Antonio D'Alessio, David James Pinato. Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 1955 doi: 10.2147/JHC.S291553
|
| 13 |
Wei Dai, Jian Wu, Shuyan Zhang, Bingjie Shi, Xinhui Xu, Danyang Wang, Jinke Wang. Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2. The International Journal of Biochemistry & Cell Biology 2017; 89: 157 doi: 10.1016/j.biocel.2017.05.031
|
| 14 |
Dongsheng Gu, Yongsheng Xie, Jingwei Wei, Wencui Li, Zhaoxiang Ye, Zhongyuan Zhu, Jie Tian, Xubin Li. MRI‐Based Radiomics Signature: A Potential Biomarker for Identifying Glypican 3‐Positive Hepatocellular Carcinoma. Journal of Magnetic Resonance Imaging 2020; 52(6): 1679 doi: 10.1002/jmri.27199
|
| 15 |
Bihui Cao, Qianqian Ni, Zhuxin Chen, Shuo Yang, Xinkui Zhang, Haotao Su, Zhenfeng Zhang, Qi Zhao, Xiaolan Zhu, Manting Liu. Development of glypican-3-specific chimeric antigen receptor-modified natural killer cells and optimization as a therapy for hepatocellular carcinoma. Journal of Leukocyte Biology 2024; doi: 10.1093/jleuko/qiae144
|
| 16 |
Bryan Fleming, Mitchell Ho. Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer. Toxins 2016; 8(10): 274 doi: 10.3390/toxins8100274
|
| 17 |
UEG Week 2018 Oral Presentations. United European Gastroenterology Journal 2018; 6(S8) doi: 10.1177/2050640618792817
|
| 18 |
Mariela Montaño-Samaniego, Diana M. Bravo-Estupiñan, Oscar Méndez-Guerrero, Ernesto Alarcón-Hernández, Miguel Ibáñez-Hernández. Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.605380
|
| 19 |
Rui Cao, Hongguang Liu , Zhen Cheng. Radiolabeled Peptide Probes for Liver Cancer Imaging. Current Medicinal Chemistry 2020; 27(41): 6968 doi: 10.2174/0929867327666200320153837
|
| 20 |
Fubo Zhou, Wenting Shang, Xiaoling Yu, Jie Tian. Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment. Medicinal Research Reviews 2018; 38(2): 741 doi: 10.1002/med.21455
|
| 21 |
Fanching Lin, Renee Clift, Takeru Ehara, Hayato Yanagida, Steven Horton, Alain Noncovich, Matt Guest, Daniel Kim, Katrina Salvador, Samantha Richardson, Terra Miller, Guangzhou Han, Abhijit Bhat, Kenneth Song, Gary Li. Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma. Journal of Nuclear Medicine 2024; 65(4): 586 doi: 10.2967/jnumed.123.266766
|
| 22 |
Rahul Agarwal, Jitendra Narayan, Amitava Bhattacharyya, Mayank Saraswat, Anil Kumar Tomar. Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets. Cancer Genetics 2017; : 37 doi: 10.1016/j.cancergen.2017.06.002
|
| 23 |
Yanli Liu, Jiaye Zhang, Yan Chen, Hasan Sohel, Xinrong Ke, Jingqi Chen, Yin-Xiong Li. The correlation and role analysis of COL4A1 and COL4A2 in hepatocarcinogenesis. Aging 2020; 12(1): 204 doi: 10.18632/aging.102610
|
| 24 |
Guangna Liu, Wei Rui, Hongli Zheng, Daosheng Huang, Fei Yu, Yuewei Zhang, Jiahong Dong, Xueqiang Zhao, Xin Lin. CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma. European Journal of Immunology 2020; 50(5): 712 doi: 10.1002/eji.201948457
|
| 25 |
Naihan Han, Wenshuang Wang, Danrong Lu, Han Wang, Xinying Ma, Xiaopeng Fan, Fuchuan Li. A novel, rapid, and sensitive homogeneous sandwich detection method of Glypican-3 as a serum marker for hepatocellular carcinoma. Chemical Communications 2017; 53(90): 12209 doi: 10.1039/C7CC06305A
|
| 26 |
Mauro Montalbano, Giuseppe Curcurù, Ali Shirafkan, Renza Vento, Cristiana Rastellini, Luca Cicalese, Francesco Cappello. Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma Lesion. PLOS ONE 2016; 11(4): e0153613 doi: 10.1371/journal.pone.0153613
|
| 27 |
Jimmy Charneau, Toshihiro Suzuki, Manami Shimomura, Norihiro Fujinami, Tetsuya Nakatsura. Peptide-Based Vaccines for Hepatocellular Carcinoma: A Review of Recent Advances. Journal of Hepatocellular Carcinoma 2021; : 1035 doi: 10.2147/JHC.S291558
|
| 28 |
Arvindhan Nagarajan, Parmanand Malvi, Narendra Wajapeyee. Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression. Frontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00483
|
| 29 |
Sai Arun Batra, Purva Rathi, Linjie Guo, Amy N. Courtney, Julien Fleurence, Julien Balzeau, Rahamthulla S. Shaik, Thao P. Nguyen, Meng-Fen Wu, Shaun Bulsara, Maksim Mamonkin, Leonid S. Metelitsa, Andras Heczey. Glypican-3–Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma. Cancer Immunology Research 2020; 8(3): 309 doi: 10.1158/2326-6066.CIR-19-0293
|
| 30 |
Alex J. Poot, Constantin Lapa, Wolfgang A. Weber, Marnix G.E.H. Lam, Matthias Eiber, Alexander Dierks, Ralph A. Bundschuh, Arthur J.A.T. Braat. [68Ga]Ga-RAYZ-8009: A Glypican-3–Targeted Diagnostic Radiopharmaceutical for Hepatocellular Carcinoma Molecular Imaging—A First-in-Human Case Series. Journal of Nuclear Medicine 2024; 65(10): 1597 doi: 10.2967/jnumed.124.268147
|
| 31 |
Daša Lipovšek, Irvith Carvajal, Alban J Allentoff, Anthony Barros, John Brailsford, Qiang Cong, Pete Cotter, Sanjeev Gangwar, Cris Hollander, Virginie Lafont, Wai Leung Lau, Wenying Li, Miguel Moreta, Steven O’Neil, Jason Pinckney, Michael J Smith, Julie Su, Christina Terragni, Michael A Wallace, Lifei Wang, Martin Wright, H Nicholas Marsh, James W Bryson. Adnectin–drug conjugates for Glypican-3-specific delivery of a cytotoxic payload to tumors. Protein Engineering, Design and Selection 2018; 31(5): 159 doi: 10.1093/protein/gzy013
|
| 32 |
Leidy D. Caraballo Galva, Xiaotao Jiang, Mohamed S. Hussein, Huajun Zhang, Rui Mao, Pierce Brody, Yibing Peng, Aiwu Ruth He, Mercy Kehinde‐Ige, Ramses Sadek, Xiangguo Qiu, Huidong Shi, Yukai He. Novel low‐avidity glypican‐3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC. Hepatology 2022; 76(2): 330 doi: 10.1002/hep.32279
|
| 33 |
Ahmad Saad, Benjamin Liet, Gilles Joucla, Xavier Santarelli, Justine Charpentier, Stéphane Claverol, Christophe F. Grosset, Véronique Trézéguet. Role of Glycanation and Convertase Maturation of Soluble Glypican-3 in Inhibiting Proliferation of Hepatocellular Carcinoma Cells. Biochemistry 2018; 57(7): 1201 doi: 10.1021/acs.biochem.7b01208
|
| 34 |
Ewelina Rodakowska, Aurelia Walczak‑Drzewiecka, Marta Borowiec, Michal Gorzkiewicz, Joanna Grzesik, Marcin Ratajewski, Michal Rozanski, Jaroslaw Dastych, Krzysztof Ginalski, Leszek Rychlewski. Recombinant immunotoxin targeting GPC3 is cytotoxic to H466 small cell lung cancer cells. Oncology Letters 2021; 21(3) doi: 10.3892/ol.2021.12483
|
| 35 |
Cristian Turato, Anna Balasso, Vinicio Carloni, Claudio Tiribelli, Francesca Mastrotto, Antonio Mazzocca, Patrizia Pontisso. New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma. Journal of Controlled Release 2017; 268: 184 doi: 10.1016/j.jconrel.2017.10.027
|
| 36 |
Yun Zhang, Jing Zhao, Jing Cai, Jia-Cong Ye, Yi-Tai Xiao, Yan Mei, Mu-Sheng Zeng, Chuan-Miao Xie, Yong Jiang, Guo-Kai Feng. Integrin α6-Targeted Magnetic Resonance Imaging of Hepatocellular Carcinoma in Mice. Molecular Imaging and Biology 2020; 22(4): 864 doi: 10.1007/s11307-019-01437-z
|
| 37 |
Maryam Mehrabi, Fatemeh Amini, Shima Mehrabi. Kill and Clearance in HCC: An Approach Based on NK Cells and Macrophages. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.693076
|
| 38 |
Amani Makkouk, Xue (Cher) Yang, Taylor Barca, Anthony Lucas, Mustafa Turkoz, Jonathan T S Wong, Kevin P Nishimoto, Mary M Brodey, Maryam Tabrizizad, Smitha R Y Gundurao, Lu Bai, Arun Bhat, Zili An, Stewart Abbot, Daulet Satpayev, Blake T Aftab, Marissa Herrman. Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer 2021; 9(12): e003441 doi: 10.1136/jitc-2021-003441
|
| 39 |
John R Couchman, Hinke Multhaupt, Ralph D. Sanderson. Recent Insights into Cell Surface Heparan Sulphate Proteoglycans and Cancer. F1000Research 2016; 5: 1541 doi: 10.12688/f1000research.8543.1
|
| 40 |
Isabel Theresa Schobert, Lynn Jeanette Savic. Current Trends in Non-Invasive Imaging of Interactions in the Liver Tumor Microenvironment Mediated by Tumor Metabolism. Cancers 2021; 13(15): 3645 doi: 10.3390/cancers13153645
|
| 41 |
Said A. Mohamed, Al-Sayed M.I. Tealeb. The role of heat shock protein 70 and glypican 3 expression in early diagnosis of hepatocellular carcinoma. Egyptian Journal of Pathology 2022; 42(2): 112 doi: 10.4103/egjp.egjp_21_22
|
| 42 |
Mahmoud Elsayed, Tarek Okda, Gamal Atwa, Gamal Omran, Atef Abd Elbaky, Abd Ramadan. Design and Optimization of Orally Administered Luteolin Nanoethosomes to Enhance Its Anti-Tumor Activity against Hepatocellular Carcinoma. Pharmaceutics 2021; 13(5): 648 doi: 10.3390/pharmaceutics13050648
|
| 43 |
Kui Chen, Andre Gorgen, Avrilynn Ding, Lulu Du, Keruo Jiang, Yu Ding, Gonzalo Sapisochin, Anand Ghanekar. Dual‐Specificity Phosphatase 9 Regulates Cellular Proliferation and Predicts Recurrence After Surgery in Hepatocellular Carcinoma. Hepatology Communications 2021; 5(7): 1310 doi: 10.1002/hep4.1701
|
| 44 |
Zhuqing Li, Kaitlin M. Bratlie. The Influence of Polysaccharides‐Based Material on Macrophage Phenotypes. Macromolecular Bioscience 2021; 21(8) doi: 10.1002/mabi.202100031
|
| 45 |
Xiaoyu Liu, Fang Gao, Longwei Jiang, Meng Jia, Lei Ao, Ming Lu, Liming Gou, Mitchell Ho, Shaochang Jia, Fei Chen, Wei Gao. 32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinoma. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02462-1
|
| 46 |
Daniel Neureiter, Sebastian Stintzing, Tobias Kiesslich, Matthias Ocker. Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets. World Journal of Gastroenterology 2019; 25(25): 3136-3150 doi: 10.3748/wjg.v25.i25.3136
|
| 47 |
Yongdong Zhang, Dongri Qiu, Ronghua Li, Yawu Liu, Shuainan Shi, Yuliang Wang. Preparation of a monoclonal antibody against the carcinoembryonic antigen, glypican‑3. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10019
|
| 48 |
Samuel Achilefu, Ramesh Raghavachari, Qi Zhang, Zhihao Han, Wancun Zhang, Zhiyu Qian, Yueqing Gu.
In vivo imaging of hepatocellular carcinoma using a glypican-3-binding peptide based probe
. Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications IX 2017; 10079: 100790T doi: 10.1117/12.2251310
|
| 49 |
Kévin Ly, Rachid Essalmani, Roxane Desjardins, Nabil G. Seidah, Robert Day. An Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) in Hepatocellular Carcinoma Cells. Journal of Biological Chemistry 2016; 291(47): 24676 doi: 10.1074/jbc.M116.746883
|
| 50 |
Seonga Park, Euni Cho, Sy-Tsong Dean Chueng, June-Sun Yoon, Taek Lee, Jin-Ho Lee. Aptameric Fluorescent Biosensors for Liver Cancer Diagnosis. Biosensors 2023; 13(6): 617 doi: 10.3390/bios13060617
|
| 51 |
Liang-Chun Yin, Zhen-Chao Luo, Yan-Xin Gao, Yang Li, Qing Peng, Yi Gao. Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/3789613
|
| 52 |
Tarek Kamal Abouzed, Fayez Althobaiti, Nesreen Adel Abdelkhlek, Ehab Bedir Eldomany, Nasr Elsayed Nasr, Kadry Mohamed Sadek, Samir Ahmed El-Shazly, Khaled A. Kahilo, Doaa Abdallha Dorghamm. Antitumor and Antioxidant Activity of S-Methyl Methionine Sulfonium Chloride against Liver Cancer Induced in Wistar Albino Rats by Diethyl Nitrosamine and Carbon Tertrachloride. International Journal of Environmental Research and Public Health 2021; 18(18): 9726 doi: 10.3390/ijerph18189726
|
| 53 |
Sylvie Ricard-Blum, Sylvain D. Vallet. Fragments generated upon extracellular matrix remodeling: Biological regulators and potential drugs. Matrix Biology 2019; : 170 doi: 10.1016/j.matbio.2017.11.005
|
| 54 |
Monica Mossenta, Davide Busato, Michele Dal Bo, Giuseppe Toffoli. Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies. Cancers 2020; 12(6): 1668 doi: 10.3390/cancers12061668
|
| 55 |
Lijuan Qin, Jiuru Wang, Fang Cheng, Jiamin Cheng, Han Zhang, Huaguo Zheng, Yongai Liu, Zhentao Liang, Baifeng Wang, Changfei Li, Haoyu Wang, Ying Ju, Huaqin Tian, Songdong Meng. GPC3 and PEG10 peptides associated with placental gp96 elicit specific T cell immunity against hepatocellular carcinoma. Cancer Immunology, Immunotherapy 2023; 72(12): 4337 doi: 10.1007/s00262-023-03569-2
|
| 56 |
Lijie Xia, Qiao Teng, Qi Chen, Fuchun Zhang. <p>Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma</p>. International Journal of Nanomedicine 2020; : 2197 doi: 10.2147/IJN.S235058
|
| 57 |
Naofumi Mukaida, Yasunari Nakamoto. Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(17): 1839-1858 doi: 10.3748/wjg.v24.i17.1839
|
| 58 |
Qi Zhang, Zhihao Han, Ji Tao, Menglu Zhao, Wancun Zhang, Ping Li, Liping Tang, Yueqing Gu. An innovative peptide with high affinity to GPC3 for hepatocellular carcinoma diagnosis. Biomaterials Science 2019; 7(1): 159 doi: 10.1039/C8BM01016A
|
| 59 |
Rui-Nan Zhang, Jian-Gao Fan. Lipid metabolism-related long noncoding RNAs: A potential prognostic biomarker for hepatocellular carcinoma. World Journal of Gastroenterology 2024; 30(33): 3799-3802 doi: 10.3748/wjg.v30.i33.3799
|
| 60 |
Lumin Lin, Yanbin He, Zhuona Ni, Min Zhang, Jie Liu, Qianqian Mao, Bin Huang, Jiumao Lin. GPC2 deficiency inhibits cell growth and metastasis in colon adenocarcinoma. Open Medicine 2022; 17(1): 304 doi: 10.1515/med-2022-0421
|
| 61 |
Xuan Liu, Jianyun Wen, Honglei Yi, Xiaorui Hou, Yue Yin, Guofu Ye, Xuedong Wu, Xiaotao Jiang. Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine release. Therapeutic Advances in Medical Oncology 2020; 12 doi: 10.1177/1758835920910347
|
| 62 |
Chunmei Xie, Christian Tiede, Xuanyi Zhang, Congrong Wang, Zhixiong Li, Xiao Xu, Michael J. McPherson, Darren C. Tomlinson, Weiwen Xu. Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10083-w
|
| 63 |
Fatemeh Motamedi Dehbarez, Navid Nezafat, Shirin Mahmoodi. In Silico Design of a Novel Multi-Epitope Peptide Vaccine Against Hepatocellular Carcinoma. Letters in Drug Design & Discovery 2020; 17(9): 1164 doi: 10.2174/1570180817999200502030038
|
| 64 |
Pooja Basthi Mohan, Siddheesh Rajpurohit, Balaji Musunuri, Ganesh Bhat, Rajiv Lochan, Shiran Shetty. Exosomes in chronic liver disease. Clinica Chimica Acta 2023; 540: 117215 doi: 10.1016/j.cca.2022.117215
|
| 65 |
Zupeng Yan, Ziyuan Che, Zhenghan Shi, Jingjiang Lv, Linhe Yang, Tianhao Lu, Yanli Lu, Jianzhen Shan, Qingjun Liu. Hepatocellular Carcinoma Detection by Cell Sensor Based on Anti-GPC3 Single-Chain Variable Fragment. Advanced Devices & Instrumentation 2024; 5 doi: 10.34133/adi.0043
|
| 66 |
Batchimeg Batbaatar, Unenbat Gurbadam, Odonchimeg Tuvshinsaikhan, Nyam-Erdene Narmandakh, Gerelee Khatanbaatar, Munkhbat Radnaabazar, Dulguun Erdene‑Ochir, Minjuur Boldbaatar, Munkhdelger Byambaragchaa, Yerbolat Amankyeldi, Munkhzaya Chogsom, Nyamsuren Ganbileg, Amgalantuul Batdelger, Tserendorj Demchig, Lkham Nyam‑Osor, Batsaikhan Bayartugs, Enkhtsatsral Batmunkh, Batkhishig Munkhjargal, Tulgaa Lonjid, Batbayar Khasbagana, Munkhbat Batmunkh, Sarantuya Jav, Munkhbayar Semchin. Evaluation of glypican‑3 in patients with hepatocellular carcinoma. Molecular and Clinical Oncology 2024; 22(1) doi: 10.3892/mco.2024.2796
|
| 67 |
Xiuzhi Zhang, Chunyan Kang, Ningning Li, Xiaoli Liu, Jinzhong Zhang, Fenglan Gao, Liping Dai. Identification of special key genes for alcohol-related hepatocellular carcinoma through bioinformatic analysis. PeerJ 2019; 7: e6375 doi: 10.7717/peerj.6375
|
| 68 |
Antonio Arulanandam, Liang Lin, Hao-Ming Chang, Martine Cerutti, Sylvie Choblet, Peng Gao, Armin Rath, Armand Bensussan, Jean Kadouche, Daniel Teper, Ofer Mandelboim, Wei Li. Derivation and Preclinical Characterization of CYT-303, a Novel NKp46-NK Cell Engager Targeting GPC3. Cells 2023; 12(7): 996 doi: 10.3390/cells12070996
|
| 69 |
Pei Wang, Wenxia Qin, Tao Liu, Duqing Jiang, Lianzhen Cui, Xiangzhen Liu, Yuan Fang, Xi Tang, Huajun Jin, Qijun Qian. PiggyBac-engineered T cells expressing a glypican-3-specific chimeric antigen receptor show potent activities against hepatocellular carcinoma. Immunobiology 2020; 225(1): 151850 doi: 10.1016/j.imbio.2019.09.009
|
| 70 |
Bijay Dhungel, Slawomir Andrzejewski, Aparna Jayachandran, Ritu Shrestha, Charmaine A. Ramlogan-Steel, Christopher J. Layton, Jason C. Steel. Evaluation of the Glypican 3 promoter for transcriptional targeting of hepatocellular carcinoma. Gene Therapy 2018; 25(2): 115 doi: 10.1038/s41434-018-0002-2
|
| 71 |
Massimiliano Berretta, Carla Cavaliere, Lara Alessandrini, Brigida Stanzione, Gaetano Facchini, Luca Balestreri, Tiziana Perin, Vincenzo Canzonieri. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications. Oncotarget 2017; 8(8): 14192 doi: 10.18632/oncotarget.13929
|
| 72 |
Weijun Wan, Yunjing Pan, Jinshu Pang, Xiumei Bai, Lipeng Li, Tong Kang, Jiamin Chen, Rong Wen, Dongyue Wen, Hong Yang, Yun He. Incomplete Thermal Ablation-Induced FOXP4-Mediated Promotion of Malignant Progression in Liver Cancer via NDST2. Journal of Hepatocellular Carcinoma 2024; : 1945 doi: 10.2147/JHC.S476612
|
| 73 |
Wafa S. Alansari, Areej A. Eskandrani. The Anticarcinogenic Effect of the Apple Polyphenol Phloretin in an Experimental Rat Model of Hepatocellular Carcinoma. Arabian Journal for Science and Engineering 2020; 45(6): 4589 doi: 10.1007/s13369-020-04478-7
|
| 74 |
Marco Di Paola, Alessandra Quarta, Francesco Conversano, Enzo Antonio Sbenaglia, Simona Bettini, Ludovico Valli, Giuseppe Gigli, Sergio Casciaro. Human Hepatocarcinoma Cell Targeting by Glypican-3 Ligand Peptide Functionalized Silica Nanoparticles: Implications for Ultrasound Molecular Imaging. Langmuir 2017; 33(18): 4490 doi: 10.1021/acs.langmuir.7b00327
|
| 75 |
Ying Liu, Shengmeng Di, Bizhi Shi, Honghong Zhang, Yi Wang, Xiuqi Wu, Hong Luo, Huamao Wang, Zonghai Li, Hua Jiang. Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3–Targeted Chimeric Antigen Receptor–Engineered T Cells in Hepatocellular Carcinoma. The Journal of Immunology 2019; 203(1): 198 doi: 10.4049/jimmunol.1800033
|
| 76 |
Meghan M. Bell, Nicholas T. Gutsche, A. Paden King, Kwamena E. Baidoo, Olivia J. Kelada, Peter L. Choyke, Freddy E. Escorcia. Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma. Molecules 2020; 26(1): 4 doi: 10.3390/molecules26010004
|
| 77 |
Zhiting Lao, Shuanqi Li, Jinhui Liang, Jingyi Su, Xin Gong, Xiping Cui, Suqing Zhao. Production and characterization of GPC3-N protein and its nanobody. Protein Expression and Purification 2022; : 106094 doi: 10.1016/j.pep.2022.106094
|
| 78 |
Ahmed Ramadan, Ashraf Omar Abdelaziz, Dina Sabry, Shaimaa Abd El tawab Fathi, Mohamed Mahmoud Nabeel, Hend Ibrahim Shousha, Tamer Mahmoud Elbaz, Rania mohamed Lithy, Hoda Ramadan Ryed. Study on molecular expression of long non-coding RNA Glypican3 in hepatocellular cancer patients. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00221-z
|
| 79 |
Mahmoud El-Bendary, Khaled Farid, Mohammad Arafa, Wagdi Elkashef, Talaat Abdullah, Ahmed El-Mesery. Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients. Journal of the Egyptian National Cancer Institute 2023; 35(1) doi: 10.1186/s43046-023-00184-1
|
| 80 |
Sanghee Lee, Sian Lee, Hyojin Lee, Seongchan Kim, Dong‐Hyun Kim. Therapeutic Glypican‐3 CRISPR Genome‐Editing Using UltraLarge Porous Silica Nano‐Depot for the Treatment of Hepatocellular Carcinoma. Small Science 2024; doi: 10.1002/smsc.202400447
|
| 81 |
Jia Duo, Camelia Chiriac, Richard Y.-C. Huang, John Mehl, Guodong Chen, Adrienne Tymiak, Peter Sabbatini, Renuka Pillutla, Yan Zhang. Slow Off-Rate Modified Aptamer (SOMAmer) as a Novel Reagent in Immunoassay Development for Accurate Soluble Glypican-3 Quantification in Clinical Samples. Analytical Chemistry 2018; 90(8): 5162 doi: 10.1021/acs.analchem.7b05277
|
| 82 |
Sheng Yu, Zhenfeng Li, Jingzhang Li, Shimei Zhao, Shanguang Wu, Hongjing Liu, Xiongjie Bi, Dongyang Li, Jiexian Dong, Siliang Duan, Bruce D. Hammock. Generation of dual functional nanobody-nanoluciferase fusion and its potential in bioluminescence enzyme immunoassay for trace glypican-3 in serum. Sensors and Actuators B: Chemical 2021; 336: 129717 doi: 10.1016/j.snb.2021.129717
|
| 83 |
Rafael FERNANDES-FERREIRA, Graciele Domitila TENANI, Marcela Augusta de Souza PINHEL, Ana Margarida Coelho ABRANTES, Maria Filomena Rabaça Roque BOTELHO, Rita de Cássia Martins Alves da SILVA, Dorotéia Rossi Silva SOUZA, Renato Ferreira da SILVA. GENES EXPRESSION AND SERUM BIOMARKERS FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA, CIRRHOSIS AND HEPATITIS C. Arquivos de Gastroenterologia 2022; 59(3): 394 doi: 10.1590/s0004-2803.202203000-71
|
| 84 |
Andrew D. Ludwig, Kevin P. Labadie, Y. David Seo, Donald K. Hamlin, Holly M. Nguyen, Vimukta M. Mahadev, Raymond S. Yeung, D. S. Wilbur, James O. Park. Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma. Journal of Oncology 2019; 2019: 1 doi: 10.1155/2019/4564707
|
| 85 |
Nasrin Abbasi Gharibkandi, Kamil Wawrowicz, Rafał Walczak, Agnieszka Majkowska-Pilip, Mateusz Wierzbicki, Aleksander Bilewicz. 109Pd/109mAg in-vivo generator in the form of nanoparticles for combined β- - Auger electron therapy of hepatocellular carcinoma. EJNMMI Radiopharmacy and Chemistry 2024; 9(1) doi: 10.1186/s41181-024-00293-9
|